AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Find creative ways to use credit card points for vacation packages and enjoy a luxurious getaway. Make your dream vacation a reality!
23,100 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
A $1 million single-life annuity paying $6,100 a month may look like strong retirement income, but it ends at death. ...
A bipartisan housing package takes effect July 11, limiting large investors owning 350+ single-family homes from acqu...
Bitcoin’s rising hodl cohorts underscore a defensive market, with on-chain metrics showing persistent outflows, minim...
Target reports a Q4 EPS beat on margin gains even as customer visits declined. The results highlight a bifurcated pat...
As aging-in-place renovations gain momentum, Block Renovation’s Julie Kheyfets outlines how ADUs and revised financin...
Epic Fury is spreading beyond energy prices, hitting travel, remittances, and food imports in Asia. The resulting pol...
Lenders say the yellow math explain about approach reveals how upfront costs and inflation expectations steer builder...
Anthropic reports an unprecedented 80-fold increase in annualized usage for Q1, fueling a rapid expansion that includ...
Analysts on Thursday issued fresh calls across a raft of names, from Commercial Metals to Wix.com, signaling continue...
Toll Brothers raises its 2026 delivery guidance on persistent luxury demand and better-than-expected absorption. The ...
Despite rates rising to 6.75%, demand remains resilient and inventory growth stays modest. Early 2026 data point to h...